Navigation Links
NeoTract Designates Dr. Ryan Chartrand as UroLift® Center of Excellence
Date:1/2/2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Dr. Ryan Chartrand, DO, Urological Services in Flint, MI has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Chartrand has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. Ryan Chartrand as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allows physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:
Jake Elguicze, 610.948.2836
Treasurer and Vice President, Investor Relations

Media:
Nicole Osmer, 650.454.0504
nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction
1. Roehrborn, J Urology 2013 LIFT Study
2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Read the full story at https://www.prweb.com/releases/neotract_designates_dr_ryan_chartrand_as_urolift_center_of_excellence/prweb16810216.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine news :

1. NeoTract Designates Dr. John Kefer as UroLift® Center of Excellence
2. NeoTract Designates Dr. Aaron Berger as UroLift® Center of Excellence
3. NeoTract Designates Dr. Garrett Matsunaga as UroLift® Center of Excellence
4. NeoTract Designates Dr. Bradley Wilson as UroLift® Center of Excellence
5. NeoTract Designates Dr. Ian M. Stormont as UroLift® Center of Excellence
6. San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June
7. The White House Designates Mercy College a Bright Spot in Hispanic Education
8. United Benefit Advisors Designates Valued Pharmacy Services as Strategic Partner
9. Prevent Blindness Designates June as Cataract Awareness Month to Help Educate Public on Leading Cause of Vision Loss and Blindness
10. Urology of Virginia Announces Designation as UroLift® Center of Excellence
11. Chesapeake Urology Announces Dr. Sankar Kausik’s Designation as UroLift® Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 26, 2020 , ... PathAI, a global provider ... of an exploratory analysis of digital scoring of PD-L1 expression to assess response in ... #2017 at the 2020 American Association for Cancer Research (AACR) Annual Meeting. AACR was ...
(Date:6/28/2020)... ... ... The secret of surviving a pandemic with one’s sanity intact does not lie in ... first product to disappear off the shelves when the COVID-19 crisis began. The idea ... to venture out, the longer you can “survive”. However, does all this doomsday-like preparation ...
(Date:6/25/2020)... ... June 25, 2020 , ... ... Best in KLAS Overall IT Services Firm, expanded its telehealth services ... Led by seasoned telehealth expert and a Consulting Magazine “2020 Women Leaders in ...
(Date:6/24/2020)... ... June 24, 2020 , ... At Allerio we have chosen ... telemedicine and remote communications. We knew it had to be portable, it had to ... it just has to work. , We are proud to announce that Allerio has ...
(Date:6/24/2020)... ... ... The world’s largest cell phone trade-in price comparison site, SellCell.com , has ... the most two years after purchase. , The SellCell analysis looked at the ... - and compared their 2018 MSRP with their trade in value this month. , ...
Breaking Medicine News(10 mins):
(Date:7/2/2020)... ... July 02, 2020 , ... Realty ... a four-part health series on its live agent Town Halls, furthering its commitment ... work. The series includes special guests and Realty ONE Group leadership discussing social, ...
(Date:7/1/2020)... HILL, Conn. (PRWEB) , ... July 01, 2020 ... ... company advancing photodynamic therapy (PDT) for treating cancer, today announced the formation of ... scientific experts who will provide critical medical, scientific, and strategic advice to support ...
(Date:6/28/2020)... ... ... CPAP Store USA, known for its one of a kind concept retail store ... at a rapid rate. Today, CPAP store USA is excited to announce the launch ... 3920 Rosemeade Parkway, Suite 150, Dallas, Texas 75287. , Opening the new retail store ...
Breaking Medicine Technology: